Quarterly report pursuant to Section 13 or 15(d)

SHAREHOLDERS??? EQUITY (Details Narrative)

v3.24.1.1.u2
SHAREHOLDERS’ EQUITY (Details Narrative)
 1 Months Ended 3 Months Ended
Mar. 12, 2024
USD ($)
shares
Mar. 12, 2024
GBP (£)
shares
Mar. 11, 2024
USD ($)
shares
Mar. 11, 2024
GBP (£)
£ / shares
shares
Dec. 15, 2023
Mar. 27, 2023
USD ($)
$ / shares
shares
Mar. 27, 2023
GBP (£)
Jan. 31, 2024
£ / shares
shares
Jan. 31, 2023
£ / shares
shares
Mar. 31, 2024
GBP (£)
£ / shares
shares
Mar. 31, 2023
GBP (£)
shares
Dec. 31, 2023
GBP (£)
£ / shares
shares
Aug. 25, 2020
£ / shares
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Payment for common stock | £                   £ 397,398   £ 397,398  
Share price | £ / shares                         £ 215.00
Ordinary shares issued                   63,902,641   20,570,088  
Number of shares issued 623,750 623,750             65,750        
Common stock, par value | £ / shares                   £ 0.0001   £ 0.0001  
Share issued price per share | £ / shares                 £ 0.0001        
Warrant to purchase of common stock           140,000              
Class of Warrant or Right, Exercise Price of Warrants or Rights | £ / shares                       £ 1.5814  
Proceeds from Issuance of Common Stock | £                   £ 19,765 £ 1,439,414    
Warrant exercise price | $ / shares           $ 100              
Warrant exercise price decrease | $ / shares           $ 35              
Proceeds from warrants exercise | £                   £ 986,772    
American depositary shares description         On December 15, 2023, the Company changed its ratio of ADSs ordinary shares from one ADS representing one ordinary share to one ADS representing 20 ordinary shares.                
Series D Warrants [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Class of Warrant or Right, Outstanding   12,475,000                      
Proceeds from warrants exercise $ 1,263,000 £ 986,772                      
Offering costs | £   £ 73,980                      
Consultant [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Number of shares issued     121,070 121,070                  
Common stock, par value | £ / shares       £ 0.0001                  
Number of shares issued for service     2,421,400 2,421,400                  
Exercise price of share options | £ / shares       £ 0.0001                  
Number od shares for service | £       £ 6,356                  
Chief Executive Officer [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Number of shares issued     23,808 23,808                  
Common stock, par value | £ / shares       £ 0.0001                  
Number of shares issued for service     476,153 476,153                  
Converted amount     $ 24,760 £ 19,765                  
Securities Second Purchase Agreement [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Number of shares issued               1,398,000 65,750        
Common stock, par value | £ / shares               £ 0.0001 £ 0.0001        
Share issued price per share | £ / shares               £ 0.0001 £ 0.0001        
Sale of Stock, Consideration Received on Transaction | £             £ 10,750            
Proceeds from Issuance of Common Stock           $ 4,900,000 4,000,000.0            
Other Expenses | £             500,000            
Common Class A [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Share price | £ / shares                   £ 215.00      
Common Class A [Member] | IPO [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Ordinary shares issued                   493,860      
Fair value of shares issued | £                   £ 3,800,000      
Deferred Shares [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Payment for common stock | £                   £ 100,000,000      
Common Stock [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Number of shares issued 12,475,000 12,475,000             1,315,000 28,436,153 1,530,000    
Common Stock [Member] | Securities Second Purchase Agreement [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Number of shares issued               27,960,000 1,315,000        
Sale of Stock, Consideration Received on Transaction | £             £ 215,000            
Prefunded Warrant [Member] | Securities Second Purchase Agreement [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Warrant to purchase of common stock           161,125              
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares           $ 32              
Series C Ordinary Warrant [Member] | Securities Second Purchase Agreement [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Warrant to purchase of common stock           171,875              
Placement Agent Warrant [Member] | Securities Second Purchase Agreement [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Warrant to purchase of common stock           12,891              
Ordinary Warrant [Member] | Securities Second Purchase Agreement [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
[custom:PrefundedWarrants] | $ / shares           $ 31.98